Detalles de la búsqueda
1.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875670
2.
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients.
Future Oncol
; 16(22): 1629-1637, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32501121
3.
PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy.
Int J Mol Sci
; 21(15)2020 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727102
4.
AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations.
Int J Mol Sci
; 21(22)2020 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33182542
5.
Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.
Int J Mol Sci
; 21(22)2020 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33266496
6.
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
Future Oncol
; 13(30): 2791-2797, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29182361
7.
Functional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer.
Future Oncol
; 9(9): 1375-88, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23980684
8.
Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors.
Front Oncol
; 13: 1193174, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519806
9.
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study.
Cancers (Basel)
; 15(19)2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835546
10.
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy.
BMC Cancer
; 12: 482, 2012 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23083011
11.
Palbociclib plus letrozole induces a complete metabolic response in metastatic breast cancer patient with idiopathic thrombocytopenia.
Recenti Prog Med
; 113(6): 376-379, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35758116
12.
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases.
Breast Care (Basel)
; 17(3): 330-335, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35957944
13.
Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition.
Front Oncol
; 12: 862806, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35719951
14.
Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution.
Clin Cancer Res
; 27(24): 6815-6823, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583970
15.
Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy.
Cancers (Basel)
; 12(10)2020 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33036192
16.
BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer.
Commun Biol
; 3(1): 546, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33004975
17.
p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.
Clin Breast Cancer
; 20(6): e761-e770, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580907
18.
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer.
Cells
; 9(2)2020 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012917
19.
Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement.
Cancer Drug Resist
; 2(4): 968-979, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582268
20.
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials.
Cancers (Basel)
; 11(11)2019 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31717791